Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Lung Cancer Patients

Histone deacetylase inhibitor (HDACi, vorinostat) responses were studied in murine and human lung cancer cell lines and genetically-engineered mouse lung cancer models. Findings were compared with a window of opportunity trial in aerodigestive tract cancers. In human (HOP62, H522 and H23) and murine...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ma, Tian, Galimberti, Fabrizio, Erkmen, Cherie P., Memoli, Vincent, Chinyengetere, Fadzai, Sempere, Lorenzo, Beumer, Jan H., Anyang, Bean N., Nugent, William, Johnstone, David, Tsongalis, Gregory J., Kurie, Jonathan M., Li, Hua, DiRenzo, James, Guo, Yongli, Freemantle, Sarah J., Dragnev, Konstantin H., Dmitrovsky, Ethan
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2013
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742691/
https://ncbi.nlm.nih.gov/pubmed/23686769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-12-0933
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items